PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extract (CY-10) rich in chlorogenic acid improves lipid accumulation in NAFLD mice by regulating the AMPK/FXR signaling pathway [PMID:38484950]
Extract (SP-8) rich in caffeoylquinic acids protects against cholestatic liver injury induced by alpha-naphthylisothiocyanate in mice [PMID:39357582]
Extracts (specifically SP-10) demonstrate hypoglycemic effects in vitro via alpha-glucosidase inhibition and in vivo during sucrose/maltose/starch tolerance assays [PMID:40872480]
Adding cup plant to feed (optimal at 5%) significantly improved specific growth rate, survival rate, and resistance to Vibrio parahaemolyticus E1 and White spot syndrome virus (WSSV) [PMID:36907480]
Evidence summary
PubMed sources
- 1.PMID: 36907480 (2023) — Investigation of the effects of cup plant (Silphium perfoliatum L.) on the growth, immunity, gut microbiota and disease resistance of Penaeus vannamei. · Fish & shellfish immunology
- 2.PMID: 36365359 (2022) — Energy vs. Nutritional Potential of Virginia Mallow (Sida hermaphrodita L.) and Cup Plant (Silphium perfoliatum L.). · Plants (Basel, Switzerland)
- 3.PMID: 12150809 (2002) — Kaempferol triosides from Silphium perfoliatum. · Phytochemistry
- 4.PMID: 38484950 (2024) — Extract of Silphium perfoliatum L. improve lipid accumulation in NAFLD mice by regulating AMPK/FXR signaling pathway. · Journal of ethnopharmacology
- 5.PMID: 36340578 (2022)